Form
SCHEDULE 13G
Passive or exempt beneficial ownership filing.
Trails Edge Capital Partners, LP - 08 Dec 2025 SCHEDULE 13G Report for Neurogene Inc. Common Stock (NGNE)
- Filing manager
- Trails Edge Capital Partners, LP
- Reporting owner
- Trails Edge Capital Partners, LP
- Security
- Neurogene Inc. Common Stock
- Beneficially owned shares
- 785,000 shares
- Large-stake signal
-
Ownership
5.1%Beneficial ownership of this reported class.
Shares
785,000 sharesShares beneficially owned as disclosed.
Event date
08 Dec 2025Date tied to the ownership event or amendment.
Accepted by SEC
15 Dec 2025EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 5.1%
- Symbol
- NGNE
- Shares outstanding
- 15,392,157 shares
- SEC form
- SCHEDULE 13G
- Accepted by SEC
- 15 Dec 2025, 18:00:02 UTC
- Event date
- 08 Dec 2025
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
4 source fields
Key filing fact
Trails Edge Capital Partners, LP disclosed 5.1% ownership in Neurogene Inc. Common Stock (NGNE) on 08 Dec 2025.
Key facts
- Trails Edge Capital Partners, LP filed SCHEDULE 13G for Neurogene Inc. Common Stock (NGNE).
- Disclosed ownership: 5.1%.
- Date of event: 08 Dec 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 Dec 2025, 18:00.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (3)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Trails Edge Capital Partners, LP | 5.1% | 785,000 | 785,000 | 0 | By: Trails Edge Capital Partners, LLC, GP of Trails Edge Capital Partners, LP /s/ Ortav Yehudai | Ortav Yehudai / Chief Investment Officer of Trails Edge Capital Partners, LLC | |
| Trails Edge Biotechnology Master Fund, LP | 5.1% | 785,000 | 785,000 | 0 | By: Trails Edge GP, LLC, GP of Trails Edge Biotechnology Fund GP, LP, GP of Trails Edge Biotechnology Master Fund, LP /s/ Ortav Yehudai | Ortav Yehudai / Chief Investment Officer of Trails Edge GP, LLC | |
| Ortav Yehudai | 5.1% | 785,000 | 785,000 | 0 | Ortav Yehudai | Ortav Yehudai / Individual |
CIK / CUSIP context first